Skip to main content

A Promising Treatment of WWOX Associated Neurological Disorders

Project description

Gene therapy for early infantile epileptic encephalopathy

Early infantile epileptic encephalopathy is a rare and severe form of encephalopathy characterised by seizures as well as the absence of language development and walking acquisition. The condition is associated with the WW domain containing the oxidoreductase (WWOX) gene and is thus also known as WWOX‐related epileptic encephalopathy (WOREE). Considering that WOREE infants have a high chance of dying prematurely, the EU-funded WWOXAID project is working on a gene therapy strategy for this syndrome. During the project, researchers will generate and validate the necessary vectors and work towards a business development plan that will bring this promising treatment to the clinic.

Host institution

THE HEBREW UNIVERSITY OF JERUSALEM
Net EU contribution
€ 150 000,00
Address
Edmond J Safra Campus Givat Ram
91904 Jerusalem
Israel

See on map

Activity type
Higher or Secondary Education Establishments
Non-EU contribution
No data

Beneficiaries (1)

THE HEBREW UNIVERSITY OF JERUSALEM
Israel
Net EU contribution
€ 150 000,00
Address
Edmond J Safra Campus Givat Ram
91904 Jerusalem

See on map

Activity type
Higher or Secondary Education Establishments
Non-EU contribution
No data